Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Sanctura distribution under way

Aug. 17, 2004

Good efficacy and safety shown for long-term use of Sanctura

Aug. 4, 2004

European approval recommended for Emselex

Aug. 3, 2004

Further positive phase I/II data for NX-1207 in BPH

Aug. 2, 2004

Chinese researchers identify novel agents for renal disorders

July 30, 2004

Novel dopamine D3 agonists and their use in sexual disorders

July 29, 2004

INNOVATION study of Micardis completes enrollment

July 28, 2004

Abbott and Deltanoid to develop fourth generation active D therapies

July 27, 2004

FDA extends Fosrenol review

July 22, 2004

Significant association found between coronary artery risk factors and erectile dysfunction

July 20, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...